2-(Dodecylsulfanyl)-6,7-dimethoxy-3-{[3-(trifluoromethyl)phenyl]methyl}-3,4-dihydroquinazolin-4-imine

Catalog No. :
ACKUWZ122
CAS No. :
439094-69-6
Molecular Formula :
C30H40F3N3O2S
Molecular Weight :
563.73

IUPAC Name:2-(dodecylthio)-6,7-dimethoxy-3-(3-(trifluoromethyl)benzyl)quinazolin-4(3H)-imine

2-(Dodecylsulfanyl)-6,7-dimethoxy-3-{[3-(trifluoromethyl)phenyl]methyl}-3,4-dihydroquinazolin-4-imine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Dodecylsulfanyl)-6,7-dimethoxy-3-{[3-(trifluoromethyl)phenyl]methyl}-3,4-dihydroquinazolin-4-imine
IUPAC Name2-(dodecylthio)-6,7-dimethoxy-3-(3-(trifluoromethyl)benzyl)quinazolin-4(3H)-imine
MDL No.MFCD02661647
Molecular FormulaC30H40F3N3O2S
Molecular Weight563.73
SMILESN=C1N(CC2=CC=CC(C(F)(F)F)=C2)C(SCCCCCCCCCCCC)=NC3=C1C=C(OC)C(OC)=C3
InChI KeyJLIRKVNDBFMSDE-UHFFFAOYSA-N
Synonym2-(DODECYLSULFANYL)-6,7-DIMETHOXY-3-[3-(TRIFLUOROMETHYL)BENZYL]-4(3H)-QUINAZOLINIMINE;2-(dodecylsulfanyl)-6,7-dimethoxy-3-{[3-(trifluoromethyl)phenyl]methyl}-3,4-dihydroquinazolin-4-imine;4(3H)-Quinazolinimine, 2-(dodecylthio)-6,7-dimethoxy-3-[[3-(trifluoromethyl)phenyl]methyl]-
CAS No.439094-69-6

Synthetic Route by SureRoute

1. ACKUWZ122 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKUWZ122 route product structure diagram
    ACKUWZ122439094-69-6
Inquiry

2. ACKUWZ122 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKUWZ122 route product structure diagram
    ACKUWZ122439094-69-6
Inquiry

Comments (0)